SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing
Financing led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare, part of M&L Group, and returning investors Sofinnova Partners and one of the largest Multinational life sciences corporations from a strategic standpoint.
Proceeds will support the completion of SafeHeal's IDE pivotal study and preparation for commercial launch of their lead technology, Colovac®.
PARIS, FRANCE AND TAMPA, FL / ACCESS Newswire / May 6, 2025 / SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced a successful completion of an oversubscribed €35 million Series C equity financing to validate the use of Colovac®, a groundbreaking temporary endoluminal fecal bypass system. Colovac is intended as an alternative to temporary diverting ostomy for patients undergoing colorectal cancer resection.
The proceeds leave SafeHeal well-funded to complete its IDE Pivotal study and accelerate preparation for commercial launch of their lead technology, Colovac.
In conjunction with the financing, Martin Sands and Steven Sands of Solar Eclipse will join as board member and observer respectively.
The Colovac endoluminal bypass system is a less-invasive alternative to temporary diverting ostomy, the current standard of care for patients undergoing colorectal resection. Diverting ostomy is applied prophylactically to most patients today undergoing a low anterior resection (LAR) and anastomosis. The ostomy temporarily diverts the stool away from the healing anastomosis to the outside of the body and into an ostomy bag. In most cases, the ostomy is needed only until the anastomosis has healed, and then it can be reversed, typically after 2-6 months. The eventual reversal of the ostomy requires another operation, with a second hospital stay, recovery period and associated complications. In some cases, the ostomy may not be reversed and becomes permanent. In addition to the potential surgical complications associated with ostomy procedures, patients may experience an impact to their quality of life due to social isolation, reduced physical activity and/or intimacy.
Colovac is an alternative to diverting ostomy, designed to eliminate the need for a temporary stoma in most patients. It aims to improve patient recovery and quality of life by eliminating stoma related complications including permanent stoma and eliminating the physical and emotional burden associated with stoma management and care.
Colovac has been successfully studied in over 100 patients in the U.S., Europe, and Asia and has received FDA Breakthrough Designation status.
'This is a very exciting time at SafeHeal as we continue to achieve a number of critical value-creating milestones in the coming months,' said Chris Richardson, President and Chief Executive Officer. 'We are grateful for the continuing support from Sofinnova Partners and delighted to welcome Solar Eclipse, Gideon and M&L Healthcare, part of M&L Group as new investors. This capital raise places SafeHeal in an excellent position to continue our momentum toward FDA approval and commercialization of Colovac.'
Chris Richardson, President & CEO, SafeHeal
'The current standard of care for treatment of Colon Resection is associated with significant morbidity, risk of permanent stoma and reduced quality of life, driving both the clinical community and regulators to search for better treatment options. SafeHeal is addressing this significant unmet medical need with a highly novel approach,' said Martin Sands of Solar Eclipse. 'I believe SafeHeal's therapeutic platform will dramatically improve quality of life and outcomes for patients with Colon Resections. I look forward to supporting the team to achieve multiple key milestones over the next 18 months.'
'We've been with SafeHeal since day one, when it was born out of our Medtech accelerator, MDStart. Our continued support in this Series C reflects a deep growing belief in their potential to revolutionize care for patients facing ostomy,' said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners.
ABOUT SAFEHEAL®
SafeHeal SAS, headquartered in Paris, France, and its wholly owned U.S. subsidiary, SafeHeal Inc., is a clinical-stage medical device company developing Colovac, a device intended as an alternative to diverting ostomy in patients undergoing colorectal surgery. Colovac is a flexible endoluminal bypass sheath designed to reduce the contact of fecal content at the anastomotic site following colorectal surgery. The device is placed endoluminally and is fully reversible. The device remains in place for 7-10 days, until the body's natural healing and tissue repair processes are complete, after which it is removed during an endoscopic procedure without the need for a second surgical intervention. This enables patients to resume their normal life without the stigma and complications associated with an ostomy procedure. Colovac is an investigational device, not currently available for sale. For more information, please visit www.safeheal.com
MEDIA CONTACTS
USA Scott DePierro Vice President U.S. Operations and Global Business Development, SafeHeal203-444-0279 Europe: Karl-Heinz Blohm Vice President, International, SafeHeal+33 (0) 6 5181 7895
###
SOURCE: SafeHeal
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
FAMU presidency controversy continues into contract conversation
A brick sign welcomes visitors to the Florida A&M campus in Tallahassee. (Photo by Jay Waagmeester/Florida Phoenix) Controversy continues to swirl around the president designate of Florida A&M University with the latest dispute over Marva Johnson's five- year contract and how she will earn her pay. FAMU Board of Trustees Chair Kristin Harper said Friday Johnson's contract puts the university at odds with the FAMU Foundation, which is responsible for providing most of the money in the contract. That's because state law caps state contributions at $200,000 annually for presidential salaries. FAMU Foundation's board chair said it could not afford a $750,000 base salary, the Tallahassee Democrat reported, which is what Johnson requested. The FAMU Foundation anticipated the new president's salary would be $588,562, Harper said, reading from a letter from the foundation. The contract says the board 'shall use its best efforts to cause the foundation to contribute to the university portions of all payments' beyond $200,000. That language concerns Harper, who said she is not sure trustees have the ability to make the foundation, a direct support organization of the university, do anything. 'I have concerns about the burden, the financial burden that this places on the university and the university's inability to fund this sweetheart deal of sweetheart deals,' Harper said. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX There was significant pushback among alumni to Johnson's candidacy much of which was centered around Johnson's political connections to former Gov. Rick Scott and Gov. Ron DeSantis. Alumni also cited the lack of higher education administration experience as a reason to reject. Johnson. Despite the opposition the FAMU Board of Trustees voted 8-4 last month to select Johnson its next president. Harper voted against selecting Johnson. After the trustees approved Johnson, the board voted to put FAMU trustee Nicole Washington in charge of negotiating the contract. At the time, Harper said she was offended. The pick to run Florida's only public HBCU is an ally to top Florida Republicans On Friday Washington disagreed with Harper's assessment about the foundation's ability to pay. 'It's my understanding that the foundation will be required to amend their budget to accommodate this expense,' Washington said. 'Required is quite a strong word,' Harper replied. Washington on Friday stood by the contract she negotiated, which was ultimately approved with an 8-3 vote. 'I compare this process to, similar to, buying a house. I still regret not buying a house back in 2017 when the median home price in Florida was $237[,000]. In 2025, that median price is $389,400, a 60% increase. The market has changed,' Washington said, calling the contract 'competitive yet balanced.' Johnson is yet to be approved by the Board of Governors. If approved, her contract would take effect Aug. 1. Total compensation would be about $840,000 in the first year and rises up to about $981,000 in the final year. Comparing the contract to other historically Black colleges and universities, the FAMU contract rises above the average HBCU contracts that search consultants evaluated of $446,094. The average of other institutions with a similar research capacity as FAMU is $617,021, according to consultants. Trustee Craig Reed took issue with the size of the contract compared to former President Larry Robinson, whose total salary was $591,669 in his last year. 'I find it highly difficult to approve a contract that significantly exceeds, essentially, what we paid our previous president that had significant experience as a sitting president and as a faculty member in a higher ed institution,' Reed said. Compared to other State University institutions, FAMU's package would land it below the 50th percentile in the first year, which is $899,644. The contract also provides Johnson a spot as a faculty member at the FAMU college of law after her presidency. One concern voiced by some trustees and a pack of people during public comment, was whether the contract prioritizes retention rather than performance. The five-year contract would start Johnson at a base salary of $650,000 with a 3% annual increase. The contract provides annual performance compensation of $86,000, if the board deems her performance worthy. For comparison, the recently negotiated University of Florida contract would've provided Santa Ono with a 20% performance bonus. Johnson's performance bonus would be approximately 13% of her salary. Her contract provides a $150,000 annual retention payment, able to be cashed out after the three and five-year marks. The retention bonus would be approximately 23% of her annual base salary. 'I'm just concerned, you know, about what matters more to this board: Occupying a seat or delivering outcomes for student success?' Harper said, adding that she would prefer that performance and retention were swapped. Trustee Zayla Bryant, a student, stood with Harper. 'And with that only being less than half of what her retention payment would be, I feel like that sets a clear standard or sets a clear indicator that her presence is more important than her performance,' Bryant said. But Washington countered that the two are intertwined. 'It's interesting that you see that as an 'either or.' I see that as a 'both and.' In order for the president to remain for three years would require that she has performed over that time,' Washington responded, adding that 'This is not a contract that anybody is going to get just for sitting in the seat.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
Wall Street Journal
6 hours ago
- Wall Street Journal
U.S. Hiring Slowed in May Amid Tariff Uncertainty - Minute Briefing
Full Transcript This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Zoe Kuhlkin: Here's your Midday Brief for Friday, June 6th. I'm Zoe Kuhlkin for The Wall Street Journal. The US added 139,000 jobs in May, the Labor Department reported today. The figure was above economists' expectations, but the slower growth serves as a sign employers remained cautious amid all of the tariff uncertainty. The employment rate, which is based on a separate survey from the jobs figures, remained at 4.2%. Federal government employment shrank by 22,000 jobs, the fourth consecutive month of such declines. Industrial production in the Eurozone's two largest economies has declined in the first month of President Trump's global tariff blitz. German and French industrial output both contracted 1.4% in April. A sign that an economic slowdown is underway after a start to the year that was even stronger than first estimated. Trade data published today showed goods exports to the US from Germany sank 10.5% as companies adapted to the new trade reality. And Switzerland has proposed some of the strictest capital rules in the world on banking giant UBS in an attempt to prevent another Credit Suisse style meltdown, protect taxpayers, and restore the country's reputation as a haven for rich people. The proposal would require UBS to hold around $26 billion in additional equity capital and reduce its reliance on hybrid bonds that can convert to equity. UBS has openly opposed this proposal and today's reforms are a blow to their arguments. The government said the main measures could take six to eight years to fully take effect. We'll have more coverage of the day's news on the WSJ's What's News Podcast. You can add it to your playlist on your smart speaker or listen and subscribe wherever you get your podcasts.
Bloomberg
7 hours ago
- Bloomberg
BNP to Cut 200 Branches by End of 2026 to Kick Off Retail Revamp
BNP Paribas SA Chief Executive Officer Jean-Laurent Bonnafe plans to cut hundreds of domestic retail branches in an effort to lift profitability at a business that has struggled for years. In a first step, the French lender plans to close around 80 branches this year and another 120 next, according to people familiar with the matter. Headcount in the branch network is expected to decline by 5% a year, while staff would be added in online and phone banking.
